Harry A. Smith
University of Kentucky
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Harry A. Smith.
Clinical Research and Regulatory Affairs | 1988
Harry A. Smith
AbstractA survey of drug product removal from the market was conducted for the years of 1980–1984 covering 24 firms and 95 products. The questionnaires were mailed to 46 firms and covered 200 products, 152 single entities and 48 combination products. Useable responses included 71 single entities and 24 combination products. The percentages of mode of product approval for the final sample were NDA 50%; ANDA, 16%, and grandfather clause, 34%. The mean life span was 20.4 years. The primary reasons for removal of the products were economic, 65%; regulatory, 27% and other, 8%. There was a significant difference in the approval modes and a marginally significant difference for the reasons of product removal from the market for the two product types. The reason for product removal was different for products approved under the three modes of approval, but this was only marginally significant statistically. The X2 test was used for these determinations. More drug products were removed from the market than were add...
Clinical Research and Regulatory Affairs | 1987
Harry A. Smith
AbstractA survey of drug product removal from the market was conducted for the years of 1980-1984 covering 24 firms and 95 products. the questionnaires were mailed to 46 firms and covered 200 products, 152 single entities and 48 combination products. Useable responses included 71 single entities and 24 combination products. the percentages of mode of product approval for the final sample were NDA 50%; ANDA, 16%, and grandfather clause, 34%. the mean life span was 20.4 years. the primary reasons for removal of the products were economic, 65%; regulatory, 27%, and other, 8%. There was a significant difference in the approval modes and a marginally significant difference for the reasons of product removal from the market for the two product types. the reason for product removal was different for products approved under the three modes of approval, but this was only marginally significant statistically. the X2 test was used for these determinations. More drug products were removed from the market than were ad...
Journal of Pharmaceutical Marketing & Management | 1990
Harry A. Smith; Stephen Joel Coons
The American Journal of Pharmaceutical Education | 1992
Harry A. Smith
Journal of Pharmaceutical Marketing & Management | 1993
Harry A. Smith; Stephen Joel Coons
Journal of The American Pharmaceutical Association | 1960
Harry A. Smith; Robert V. Evanson; Glen J. Sperandio
The American Journal of Pharmaceutical Education | 1990
Harry A. Smith
Journal of Pharmaceutical Marketing & Management | 1990
Harry A. Smith; Stephen Joel Coons
Archive | 1992
Harry A. Smith; Stephen Joel Coons
The American Journal of Pharmaceutical Education | 1983
Harry A. Smith; Joseph V. Swintosky